Quotient Sciences

About, Contact Details

PRESENTATION(s)

Corporate Presentation, 14C Human ADME Program for HTD1801, Oxilio & Quotient Announce Regulatory Approval for OXL001, Expansion of Facilities for Translational Pharmaceutics® Programs, Ensysce Biosciences & Quotient Announce a Partnership, Human ADME Studies, Bioanalytical Services, Translational Pharmaceutics®, Formulation Strategies for Poorly Soluble Molecules, Global Formulation Development & Manufacturing Capabilities, Commercial Manufacturing, Clinical Trial Manufacturing, Global Clinical Trial Supplies, GMP Certificate 2019, Financial Impact of Translational Pharmaceutics®, High Potency Handling, Project Management at Quotient Sciences, Pediatrics Services, Formulation Development, Clinical Pharmacology

VIDEO(s)

Corporate Video, Our Manifesto, Miami Clinical Pharmacology Facility

DIGITAL CONTENT

2 Interviews #SpeakPharma, 110 News

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

SERVICES

All Services, Analytical, Clinical Trials, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development, Packaging

KEY SERVICES

Pharmacy Compounding Services, Pharmacy Compounding & Formulation Services, Formulation Development of Capsules, Development of Nasal Dosage Forms, Development of Pediatric Formulations, CDMO for Suspensions, Drug Substance Synthesis and Manufacturing